Development of a Targeted SN-38-Conjugate for the Treatment of Glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a Targeted SN-38-Conjugate for the Treatment of Glioblastoma

Published:2024-01-04 Issue:2 Volume:9 Page:2615-2628
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Bataille Backer Perpetue¹,Adekiya Tayo Alex¹,Kim Yushin²,Reid Terry-Elinor R.²,Thomas Michael³,Adesina Simeon K.¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, Howard University, Washington D.C. 20059, United States

2. Department of Pharmaceutical Sciences, Concordia University of Wisconsin, Mequon, Wisconsin 53097-2402, United States

3. Department of Biology, Howard University, Washington D.C. 20059, United States

Funder

Health Resources and Services Administration

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c07486

Reference65 articles.

1. A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood–Brain Barrier Permeability and Targets Glioblastoma

2. Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects

3. Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches

4. Frontiers in the treatment of glioblastoma: Past, present and emerging

5.

Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted delivery of SN38 to breast cancer using amphiphilic diblock copolymers PHPMA-b-PBAEM as micellar carriers with AS1411 aptamer;International Journal of Pharmaceutics;2024-08

2. Targeted Delivery of Nanoparticle-Conveyed Neutrophils to the Glioblastoma Site for Efficient Therapy;ACS Applied Materials & Interfaces;2024-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3